Impact Biotech

Impact Biotech company information, Employees & Contact Information

Explore related pages

Related company profiles:

ImPact Biotech is focused on the development and launch of Padeliporfin VTP (Vascular Targeted Photodynamic) therapy for the treatment of solid tumors. The company is headquartered in Israel, with presence in Luxembourg, France and USA, as well as its own GMP-certified (Good Manufacturing Practice) facility and research center in Israel. ImPact Biotech holds exclusive rights from the Weizmann Institute of Science (WIS, Israel) and Memorial Sloan Kettering Cancer Center (MSKCC, New York), to develop and commercialize drugs and related technologies used in VTP.

Company Details

Employees
40
Founded
-
Address
16 Einstein St., Ness Ziona,israel 7403622,israel
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Ness Ziona, Israel
Looking for a particular Impact Biotech employee's phone or email?

Impact Biotech Questions

News

Steba Biotech receives FDA Orphan Drug Designation for Padeliporfin ImPACT in Upper Tract Urothelial Cancer - GlobeNewswire

Steba Biotech receives FDA Orphan Drug Designation for Padeliporfin ImPACT in Upper Tract Urothelial Cancer GlobeNewswire

FDA grants Orphan Drug designation to padeliporfin ImPACT for UTUC - Urology Times

FDA grants Orphan Drug designation to padeliporfin ImPACT for UTUC Urology Times

TOOKAD Soluble approved for prostate cancer therapy in Mexico - Medical Xpress

TOOKAD Soluble approved for prostate cancer therapy in Mexico Medical Xpress

Top Impact Biotech Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant